For research teamsHelp me find a study
Back to all studies
TerminatedNCT01122927

Flexible-Dose Oral Aripiprazole for schizophrenia

This study was terminated in the United States, in Bulgaria, in Croatia, .... It is testing Flexible-Dose Oral Aripiprazole for schizophrenia.

Bipolarity, SchizophreniaDrugFrom 10 Years to 17 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Aripiprazole may be useful for adolescents experiencing bipolarity.

What would participation involve?

Participants may receive Aripiprazole, attend study visits with the research team. The registry lists locations in Bulgaria, in Croatia, and in Hungary.

Who is it mainly for?

This study appears to be mainly for adolescents with bipolarity. Because it involves minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateJuly 2010
Recruitment status
Terminated
Enrollment listed in the registry
524
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Bulgaria, Croatia, ...
Age range
From 10 Years to 17 Years
Official registry ID
NCT01122927
Official title
A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia or Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01122927. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Bulgaria · 8 sites
  • Study Site
    Burgas
    Site status: Not listed — confirm with the team
  • Study Site
    Pazardzhik
    Site status: Not listed — confirm with the team
  • Study Site
    Plovdiv
    Site status: Not listed — confirm with the team
  • Study Site
    Rousse
    Site status: Not listed — confirm with the team
  • Study Site 2
    Sofia
    Site status: Not listed — confirm with the team
  • Study Site
    Targovishte
    Site status: Not listed — confirm with the team
  • Study Site 1
    Varna
    Site status: Not listed — confirm with the team
  • Study Site 2
    Varna
    Site status: Not listed — confirm with the team
Croatia · 3 sites
  • Study Site
    Rijeka
    Site status: Not listed — confirm with the team
  • Study Site 1
    Zagreb
    Site status: Not listed — confirm with the team
  • Study Site 2
    Zagreb
    Site status: Not listed — confirm with the team
Hungary · 4 sites
  • Study Site
    Budapest
    Site status: Not listed — confirm with the team
  • Study Site
    Budapest
    Site status: Not listed — confirm with the team
  • Study Site
    Gyula
    Site status: Not listed — confirm with the team
  • Study Site
    Szeged
    Site status: Not listed — confirm with the team
India · 18 sites
  • Study Site
    Vijayawada, Andhra Pradesh
    Site status: Not listed — confirm with the team
  • Study Site
    Visakhapatnam, Andhra Pradesh
    Site status: Not listed — confirm with the team
  • Study Site
    Visakhapatnam, Andhra Pradesh
    Site status: Not listed — confirm with the team
  • Study Site 1
    Ahmedabad, Gujarat
    Site status: Not listed — confirm with the team
  • Study Site 2
    Ahmedabad, Gujarat
    Site status: Not listed — confirm with the team
  • Study Site
    Ahmedabad, Gujarat
    Site status: Not listed — confirm with the team
  • Study Site
    Maninagar, Ahmedabad, Gujarat
    Site status: Not listed — confirm with the team
  • Study Site
    Mangalore, Karnataka
    Site status: Not listed — confirm with the team
  • Study Site
    Calicut, Kerala
    Site status: Not listed — confirm with the team
  • Study Site
    Nashik, Maharashtra
    Site status: Not listed — confirm with the team
  • Study Site
    Ludhiana, Punjab
    Site status: Not listed — confirm with the team
  • Study Site
    Jaipur, Rajasthan
    Site status: Not listed — confirm with the team
  • Study Site
    Chennai, Tamil Nadu
    Site status: Not listed — confirm with the team
  • Study Site
    Maduri, Tamil Nadu
    Site status: Not listed — confirm with the team
  • Study Site
    Kanpur, Uttar Pradesh
    Site status: Not listed — confirm with the team
  • Study Site
    Lucknow, Uttar Pradesh
    Site status: Not listed — confirm with the team
  • Study Site
    Varanasi, Uttar Pradesh
    Site status: Not listed — confirm with the team
  • Study Site
    Guntur
    Site status: Not listed — confirm with the team
Malaysia · 1 site
  • Study Site
    Kuala Lumpur, Kuala Lumpur
    Site status: Not listed — confirm with the team
Philippines · 4 sites
  • Study Site
    Dasmariñas, Cavite
    Site status: Not listed — confirm with the team
  • Study Site
    Manila, National Capital Region
    Site status: Not listed — confirm with the team
  • Study Site
    Iloilo City
    Site status: Not listed — confirm with the team
  • Study Site
    Mandaluyong
    Site status: Not listed — confirm with the team
Poland · 5 sites
  • Study Site
    Bialystok
    Site status: Not listed — confirm with the team
  • Study Site
    Gdansk Wrzeszcz
    Site status: Not listed — confirm with the team
  • Study Site
    Torun
    Site status: Not listed — confirm with the team
  • Study Site
    Wroclaw
    Site status: Not listed — confirm with the team
  • Study Site
    Wroclaw
    Site status: Not listed — confirm with the team
Romania · 5 sites
  • Study Site
    Cluj-Napoca, Cluj
    Site status: Not listed — confirm with the team
  • Study Site
    Timișoara, Timiș County
    Site status: Not listed — confirm with the team
  • Study Site
    Bucharest
    Site status: Not listed — confirm with the team
  • Study Site
    Craiova, Dolj
    Site status: Not listed — confirm with the team
  • Study Site
    Iași
    Site status: Not listed — confirm with the team
Russia · 15 sites
  • Study Site
    Nizhny Novgorod, Russian Federation
    Site status: Not listed — confirm with the team
  • Study Site
    Novosibirsk, Russian Federation
    Site status: Not listed — confirm with the team
  • Study Site
    Tonnelnyi Township, Russian Federation
    Site status: Not listed — confirm with the team
  • Study Site
    Kazan'
    Site status: Not listed — confirm with the team
  • Study Site
    Lipetsk
    Site status: Not listed — confirm with the team
  • Study Site
    Moscow
    Site status: Not listed — confirm with the team
  • Study Site
    Moscow
    Site status: Not listed — confirm with the team
  • Study Site
    Orenburg Region
    Site status: Not listed — confirm with the team
  • Study Site
    Petrozavodsk
    Site status: Not listed — confirm with the team
  • Study Site
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Study Site
    Saint Petersburg
    Site status: Not listed — confirm with the team
  • Study Site
    Saratov
    Site status: Not listed — confirm with the team
  • Study Site
    Tomsk
    Site status: Not listed — confirm with the team
  • Study Site
    Yaroslavl
    Site status: Not listed — confirm with the team
  • Study Site
    Yekaterinburg
    Site status: Not listed — confirm with the team
Serbia · 3 sites
  • Study Site 1
    Belgrade
    Site status: Not listed — confirm with the team
  • Study Site 2
    Belgrade
    Site status: Not listed — confirm with the team
  • Study Site
    Novi Sad
    Site status: Not listed — confirm with the team
Taiwan · 1 site
  • Study Site
    Taipei
    Site status: Not listed — confirm with the team
Ukraine · 11 sites
  • Study Site
    Dnipro
    Site status: Not listed — confirm with the team
  • Study Site
    Donetsk
    Site status: Not listed — confirm with the team
  • Study Site 1
    Kharkiv
    Site status: Not listed — confirm with the team
  • Study Site 2
    Kharkiv
    Site status: Not listed — confirm with the team
  • Study Site
    Kherson
    Site status: Not listed — confirm with the team
  • Study Site
    Luhansk
    Site status: Not listed — confirm with the team
  • Study Site
    Lviv
    Site status: Not listed — confirm with the team
  • Study Site
    Odesa
    Site status: Not listed — confirm with the team
  • Study Site
    Simferopol Crimea
    Site status: Not listed — confirm with the team
  • Study Site
    Temopil
    Site status: Not listed — confirm with the team
  • Study Site
    Vinnytsia
    Site status: Not listed — confirm with the team
United States · 23 sites
  • Study Site
    Dothan, Alabama
    Site status: Not listed — confirm with the team
  • Study Site
    Downey, California
    Site status: Not listed — confirm with the team
  • Study Site
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Study Site
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Study Site
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Study Site
    Smyrna, Georgia
    Site status: Not listed — confirm with the team
  • Study Site
    Oak Brook, Illinois
    Site status: Not listed — confirm with the team
  • Study Site
    Wichita, Kansas
    Site status: Not listed — confirm with the team
  • Study Site
    Minneapolis, Minnesota
    Site status: Not listed — confirm with the team
  • Study Site
    Buffalo, New York
    Site status: Not listed — confirm with the team
  • Study Site
    Stony Brook, New York
    Site status: Not listed — confirm with the team
  • Study Site
    Chapel Hill, North Carolina
    Site status: Not listed — confirm with the team
  • Study Site
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • Study Site
    Cleveland, Ohio
    Site status: Not listed — confirm with the team
  • Study Site
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Study Site
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Study Site
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Study Site
    San Antonio, Texas
    Site status: Not listed — confirm with the team
  • Study Site
    The Woodlands, Texas
    Site status: Not listed — confirm with the team
  • Study Site
    Richmond, Virginia
    Site status: Not listed — confirm with the team
  • Study Site
    Bellevue, Washington
    Site status: Not listed — confirm with the team
  • Study Site
    Bothell, Washington
    Site status: Not listed — confirm with the team
  • Study Site
    Milwaukee, Wisconsin
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Aripiprazole. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with bipolarity; age range: From 10 Years to 17 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., which appears to be a pharmaceutical company. Sponsor website: https://www.otsuka.co.jp/en/. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.